Maurizis JC - Search Results

1

Pharmacokinetic study of cystemustine, administered on a weekly schedule in cancer patients.

Cellarier E, Terret C, Labarre P, Ouabdesselam R, Curé H, Marchenay C, Maurizis JC, Madelmont JC, Cholle P, Armand JP. Cellarier E, et al. Among authors: maurizis jc. Ann Oncol. 2002 May;13(5):760-9. doi: 10.1093/annonc/mdf098. Ann Oncol. 2002. PMID: 12075746 Free article. Clinical Trial.

2

A new O6-alkylguanine-DNA alkyltransferase inhibitor associated with a nitrosourea (cystemustine) validates a strategy of melanoma-targeted therapy in murine B16 and human-resistant M4Beu melanoma xenograft models.

Rapp M, Maurizis JC, Papon J, Labarre P, Wu TD, Croisy A, Guerquin-Kern JL, Madelmont JC, Mounetou E. Rapp M, et al. Among authors: maurizis jc. J Pharmacol Exp Ther. 2008 Jul;326(1):171-7. doi: 10.1124/jpet.108.137737. Epub 2008 Apr 14. J Pharmacol Exp Ther. 2008. PMID: 18411412

3

Enhancement by O6-benzyl-N-acetylguanosine derivatives of chloroethylnitrosourea antitumor action in chloroethylnitrosourea-resistant human malignant melanocytes.

Cussac C, Rapp M, Mounetou E, Madelmont JC, Maurizis JC, Godeneche D, Dupuy JM, Sauzieres J, Baudry JP, Veyre A. Cussac C, et al. Among authors: maurizis jc. J Pharmacol Exp Ther. 1994 Dec;271(3):1353-8. J Pharmacol Exp Ther. 1994. PMID: 7996446

4

Enhancement by O6-benzyl-N2-acetylguanosine of N'-[2-chloroethyl]-N-[2-(methylsulphonyl)ethyl]-N'-nitrosourea therapeutic index on nude mice bearing resistant human melanoma.

Debiton E, Cussac-Buchdhal C, Mounetou E, Rapp M, Dupuy JM, Maurizis JC, Veyre A, Madelmont JC. Debiton E, et al. Among authors: maurizis jc. Br J Cancer. 1997;76(9):1157-62. doi: 10.1038/bjc.1997.527. Br J Cancer. 1997. PMID: 9365163 Free PMC article.

5

Methionine dependency and cancer treatment.

Cellarier E, Durando X, Vasson MP, Farges MC, Demiden A, Maurizis JC, Madelmont JC, Chollet P. Cellarier E, et al. Among authors: maurizis jc. Cancer Treat Rev. 2003 Dec;29(6):489-99. doi: 10.1016/s0305-7372(03)00118-x. Cancer Treat Rev. 2003. PMID: 14585259 Review.

6

Application to a cartilage targeting strategy: synthesis and in vivo biodistribution of (14)C-labeled quaternary ammonium-glucosamine conjugates.

Giraud I, Rapp M, Maurizis JC, Madelmont JC. Giraud I, et al. Among authors: maurizis jc. Bioconjug Chem. 2000 Mar-Apr;11(2):212-8. doi: 10.1021/bc990128+. Bioconjug Chem. 2000. PMID: 10725098

7

Metabolism of a new radioprotector; S-acetyl-N-glycyl cysteamine. I. Absorption, distribution and excretion metabolites in mice bearing EMT6 tumours.

Maurizis JC, Godeneche D, Madelmont JC, Moreau MF, Oiry J, Imbach JL, Veyre A. Maurizis JC, et al. Xenobiotica. 1988 Oct;18(10):1119-28. doi: 10.3109/00498258809042234. Xenobiotica. 1988. PMID: 3242308

8

Disposition in rat of a new fluorinated, biocompatible, non-ionic telomeric carrier.

Maurizis JC, Azim M, Rapp M, Pucci B, Pavia A, Madelmont JC, Veyre A. Maurizis JC, et al. Xenobiotica. 1994 Jun;24(6):535-41. doi: 10.3109/00498259409043256. Xenobiotica. 1994. PMID: 7975719

9

Disposition and metabolism of 2,6-dimethylbenzamide N-(5-methyl-3-isoxazolyl) (D2916) in male and female rats.

Maurizis JC, Madelmont JC, Rapp M, Marijnen C, Cerf MC, Gillardin JM, Lepage F, Veyre A. Maurizis JC, et al. Drug Metab Dispos. 1997 Jan;25(1):33-9. Drug Metab Dispos. 1997. PMID: 9010627

10

New quaternary ammonium oxicam derivatives targeted toward cartilage: synthesis, pharmacokinetic studies, and antiinflammatory potency.

Nicolas C, Verny M, Giraud I, Ollier M, Rapp M, Maurizis JC, Madelmont JC. Nicolas C, et al. Among authors: maurizis jc. J Med Chem. 1999 Dec 16;42(25):5235-40. doi: 10.1021/jm991120o. J Med Chem. 1999. PMID: 10602708

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73 results

Search Page

Filters